Amiloride Interactions

Concomitant use can produce severe hyperkalemia. Contraindicated.

Source: NLP:potassium chloride

Concomitant administration can produce severe hyperkalemia and should be avoided.

Source: NLP:potassium citrate

Potassium-sparing diuretic can increase the risk of hyperkalemia. Frequent monitoring of serum potassium is recommended if concomitant use is indicated.

Source: NLP:amlodipine besylate and benazepril hydrochloride

Potassium-sparing diuretic may lead to significant increases in serum potassium. Avoid in heart failure patients.

Source: NLP:enalapril

Potassium-sparing diuretic that can increase risk of hyperkalemia when used with fosinopril. Requires caution and frequent monitoring of serum potassium levels.

Source: NLP:fosinopril

Potassium-sparing diuretic can increase risk of hyperkalemia when used with lisinopril; requires frequent monitoring of serum potassium.

Source: NLP:lisinopril

Concomitant use may lead to increases in serum potassium, which can be serious.

Source: NLP:losartan potassium

Potassium-sparing diuretic may lead to increases in serum potassium. Monitoring of serum potassium is advisable.

Source: NLP:olmesartan medoxomil

Potassium-sparing diuretic increases risk of hyperkalemia. Frequent monitoring of serum potassium recommended if concomitant use indicated.

Source: NLP:ramipril

Increased risk of severe and potentially fatal hyperkalemia when potassium chloride solution is administered.

Source: NLP:sodium chloride, soldium lactate, potassium chloride and calcium chloride

Potassium-sparing diuretic may lead to increases in serum potassium and in heart failure patients, increases in serum creatinine. Monitoring of serum potassium is advisable.

Source: NLP:valsartan

Potassium-sparing diuretic may lead to increases in serum potassium and in heart failure patients to increases in serum creatinine when used with valsartan.

Source: NLP:valsartan and hydrochlorothiazide

Potassium-sparing diuretic that may increase serum potassium when combined with valsartan. Monitor serum potassium levels.

Source: NLP:amlodipine and valsartan

Increased risk of hyperkalemia. Monitor serum potassium frequently during concomitant use.

Source: NLP:benazepril hydrochloride

Potassium-sparing diuretic may lead to significant increases in serum potassium. Avoid in patients with heart failure.

Source: NLP:enalapril maleate

Potassium-sparing diuretic may lead to significant increases in serum potassium when combined with enalapril. Avoid in heart failure patients.

Source: NLP:enalapril maleate oral solution

Potassium-sparing diuretic may lead to significant increases in serum potassium when used concomitantly with enalaprilat. Use with caution and monitor serum potassium frequently.

Source: NLP:enalaprilat

Potassium-sparing diuretic may increase risk of hyperkalemia when used with fosinopril sodium and hydrochlorothiazide; requires monitoring of serum potassium.

Source: NLP:fosinopril sodium and hydrochlorothiazide

Cationic drug eliminated by renal tubular secretion with potential for interaction with metformin by competing for common renal tubular transport systems.

Source: NLP:metformin hcl

Potassium-sparing diuretic may increase risk of hyperkalemia when used concomitantly with moexipril. Requires caution and monitoring of serum potassium levels.

Source: NLP:moexipril hydrochloride

May lead to increased serum potassium levels. Monitor potassium during concomitant use.

Source: NLP:sacubitril and valsartan

Potassium-sparing diuretic that can increase risk of hyperkalemia when used concomitantly with trandolapril. Use with caution and monitor serum potassium.

Source: NLP:trandolapril